Edity Therapeutics logo
VerifiedBiotechnology Research· Founded 2020

Edity Therapeutics

Edity is developing a novel delivery platform that uses immune cells to transfer therapeutic proteins to the target cells of patients. Our technology allows for precise modulation of intracellular pathways of disease using a range of proteins including gene editors, immune sensors, enzymes and intrabodies.

7-day free trial · no credit card

HeadquartersRehovot Israel, IsraelEmployees23(11 to 50)Founded year2020Websiteedity-tx.comLinkedIn profileLinkedIn

Verified contacts

23

available on Kipplo

LinkedIn employees

23

11 to 50 range

Open roles

no listings

Distinct roles

15

indexed titles

Tech stack

0

tools in use

Monthly traffic

45

organic / mo

Sign up free to see all 23 verified contacts at Edity Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

23 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Edity Therapeutics

15 distinct titles indexed · top 10 shown.

  • 4research assistant
  • 2president
  • 2researcher
  • 2team lead
  • 1co-founder
  • 1director core technology research at edity therapeutics
  • 1executive assistant & office manager
  • 1founder & ceo
  • 1head of vaccine therapeutics
  • 1ip manager
  • +5more titles

Sign up to unlock all 23 contacts at Edity Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 23 verified contacts at Edity Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Edity Therapeutics | Kipplo Discover